Offer - Urjas Oil for just ₹ 1
Epirubitec 50 Injection, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Breast Cancer.
Medical history of the patient along with age and gender determines the dosage of Epirubitec 50 Injection. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Epirubitec 50 Injection as well, which are listed below. Such side effects of Epirubitec 50 Injection normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Epirubitec 50 Injection's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Epirubitec 50 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Epirubitec 50 Injection contraindications section.
Drug reaction of Epirubitec 50 Injection with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Epirubitec 50 Injection is considered not safe while driving, and is not addictive.
Epirubitec 50 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
| Geriatric |
|
Is the use of Epirubitec 50 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Epirubitec. If you are pregnant, do not take Epirubitec without a doctor's advice.
Is the use of Epirubitec 50 Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Epirubitec. So it is adviced to consult the doctor before using it.
What is the effect of Epirubitec 50 Injection on the Kidneys?
Epirubitec can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Epirubitec 50 Injection on the Liver?
You may experience side effects on your liver after taking Epirubitec. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Epirubitec 50 Injection on the Heart?
The heart can be affected by Epirubitec. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Epirubitec 50 Injection unless your doctor advises you to do so -
Is this Epirubitec 50 Injection habit forming or addictive?
Epirubitec 50 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Epirubitec 50 Injection, you should not drive or work on any heavy machine, as Epirubitec 50 Injection can make you drowsy.
Is it safe?
Yes, Epirubitec 50 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Epirubitec 50 Injection is not used to treat mental disorders.
Interaction between Food and Epirubitec 50 Injection
It is safe to take Epirubitec 50 Injection with food.
Interaction between Alcohol and Epirubitec 50 Injection
Taking alcohol with Epirubitec 50 Injection can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ellence® (epirubicin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 505-508
